Long-term Follow-up Study of Patients Receiving CAR-T Cells

Launched by MEDICAL COLLEGE OF WISCONSIN · Dec 14, 2017

Keywords

ClinConnect Summary

This clinical trial is a long-term follow-up study for patients who have received CAR-T cell therapy as part of earlier clinical trials at the Medical College of Wisconsin and Froedtert Hospital. CAR-T cell therapy is a type of treatment that helps the body fight certain types of blood cancers, including various forms of lymphoma and multiple myeloma. The goal of this study is to monitor the health and outcomes of these patients over time to better understand the long-term effects of the therapy.

If you or a loved one participated in a CAR-T study at this hospital, you may be eligible to join this follow-up study. There are no specific exclusions, so anyone who has taken part in these CAR-T trials can participate. In this study, participants can expect regular check-ins and assessments to track their health and any changes they may experience after treatment. This study is important because it helps researchers gather valuable information that can improve future treatments and patient care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All participants who enrolled in a CAR-T study at Froedtert Hospital \& the Medical College of Wisconsin.
• Exclusion Criteria:
• • There are no exclusion criteria for this study.